Across TCGA pan-cancer cohorts, MIR570 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of MIR570’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR570 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR570 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.
KIRC, LIHC, and THCA are the cancer types where MIR570 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR570 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.